Publication Date




Download Full Text (593 KB)


Juvenile idiopathic arthritis (JIA) is the most common chronic inflammatory disease seen in pediatric rheumatology. Despite advances in biologic therapy, many children with JIA will experience morbidity. Treat to Target is a treatment paradigm that involves setting a target of disease activity, using shared decision making, and incorporating clinical decision support. Our clinic aimed to set a treatment target on 50% of eligible JIA patients by December 31, 2019.

MeSH Keywords

Arthritis, Juvenile; Child; Adolescent; Quality Improvement; Disease Management


Treat to Target


Pediatric Nursing | Pediatrics | Rheumatology


National Healthcare Quality Week


Acknowledgements: We thank Drs. Maria Ibarra, Cara Hoffart, and Jordan Jones in addition to rheumatology nurses, Amy Ivy, and all of our participating patients and families.

Implementing Treat to Target Approach in the Care of Children with Juvenile Idiopathic Arthritis



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.